Advanced Oncotherapy - Technological update
AVO Tue, 05 Sep 2017, 09:05am BST
Nicolas Serandour, CEO of Advanced Oncotherapy, discusses the details of the technological update and it representing significant progress in validating the capabilities of the first in the next group of accelerating components. Following these successful trials, the Company remains on track to build a proton therapy system capable of treating superficial tumours by the end of Q3 2018.
Nicolas Serandour
CEO
Nicolas Serandour, CEO
Mon, 11 Dec 2017, 7:00am GMT
AVO Team, AVO Team
Mon, 23 Oct 2017, 7:00am BST
Nicolas Serandour, CEO
Tue, 5 Sep 2017, 9:05am BST
AVO Team, AVO Team
Thu, 3 Aug 2017, 9:00am BST
Mick Durie, Director, Deconstruct
Wed, 5 Jul 2017, 6:30am BST